Corneal graft failure due to migration of Ozurdex™ implant into the anterior chamber

نویسندگان

  • Haifa A. Madi
  • Stephen J. Morgan
  • Saurabh Ghosh
چکیده

Purpose We report a case of corneal endothelial graft failure secondary to dexamethasone intravitreal implant (Ozurdex™) migration into the anterior chamber (AC). Observations A 53-year-old man with a history of bilateral idiopathic chronic uveitis, had a right anterior vitrectomy and AC intraocular lens (ACIOL) with a peripheral iridotomy. He received an intravitreal Ozurdex™ implant for right cystoid macular oedema (CMO). Three months later he developed pseudophakic bullous keratopathy and underwent a Descemet stripping automated endothelial keratoplasty (DSAEK), combined with IOL exchange (ACIOL explantation followed by scleral fixated posterior chamber IOL). He developed recurrent CMO post-operatively, for which he had a second Ozurdex™ implant. Six weeks following the implant he presented with reduced vision and corneal graft failure with migration of the Ozurdex™ implant into the AC. Despite prompt surgical removal of the implant, the graft did not recover and he underwent a repeat DSAEK. Conclusions and importance Ophthalmologists should be aware of this adverse event and the importance of early implant removal to reduce the risk of permanent corneal oedema.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Management of anterior chamber dislocation of a dexamethasone intravitreal implant: a case report

BACKGROUND Ozurdex is a 700 mcg dexamethasone intravitreal implant, approved for the management of macular edema secondary to retinal vein occlusion, and other related pathoglogiesAnterior chamber dislocation of Ozurdex represents an uncommon complication of the intravitreal injection, which can be managed by repositioning the implant into the vitreous cavity. We describe the case of a successf...

متن کامل

Wandering Ozurdex® implant

PURPOSE To report the behavior of intravitreal Ozurdex(®) implant in eyes with post-lensectomy-vitrectomy (PLV) aphakia. METHODS Retrospective chart review of three eyes with PLV aphakia (three patients with uveitis) who received intravitreal injection of Ozurdex(®) for cystoid macular edema (one eye), persistent inflammation (one eye), and ocular hypotony (one eye). Final outcome was assesse...

متن کامل

[Ozurdex(®) and aphakia: a combination to avoid].

zurdex® (Allergan Inc., Irvine, CA, USA) is a biodegradable mplant for the sustained release of intravitreal dexamethaone which has recently been approved as a treatment for acular edema secondary to retinal venous occlusion and n posterior uveitis of non-infectious cause.1 Ozurdex® has lso demonstrated its efficiency in diabetic and pseudophakic acular edema. Before it was placed on the market...

متن کامل

Risk Factors for Failure of Keratoplasty in Keratoconus: Penetrating vs. Deep Anterior Lamellar Keratoplasty

Purpose: To determine the etiologic factors on rejection and failure rates and ocular surface changes after corneal transplantation by either DALK or PKP, in cases of keratoconus (KCN). Methods: In this cross-sectional study, considering the existing data, patients with keratoconus referring to Labbafinejad Medical Center from 2006 to 2016, who underwent corneal transplantation, were enrolled a...

متن کامل

Double Descemet Membrane Forming a Double Anterior Chamber

Purpose: To report a case of double descemet membrane forming a double anterior chamber following ‘Big bubble’ DALK converted to PKP. Results: A 52-year-old man with keratoconus underwent DALK operation converted to PKP due to macro perforation of the descemet membrane. On the postoperative evaluation a remnant of the host’s descemet membrane formed a double anterior chamber. After a few months...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:

دوره 8  شماره 

صفحات  -

تاریخ انتشار 2012